Pet Releaf, a leading provider of hemp-based supplements for dogs and cats, has been named to the Board of the U.S. Hemp Roundtable, marking a significant step forward in national advocacy for pet wellness. The company will now directly influence policy and promote acceptable standards for pet products in the quickly changing hemp market, following years of active participation and engagement.
The leading national advocacy group for the hemp industry, the U.S. Hemp Roundtable represents a broad coalition of farmers, companies, merchants, and industry advocates striving to create safe, transparent, and uniform hemp laws throughout the country. The addition of Pet Releaf to the Board demonstrates the increasing significance of pet wellness in federal and state regulatory discourse.
“Pet Releaf has joined the Board of the U.S. Hemp Roundtable, giving pets a strong voice at the industry’s most influential table,” said Paul Gennings, J.D., Vice President of Legal, Quality & Regulatory Affairs at Pet Releaf. “As hemp laws continue to evolve, we’re committed to ensuring the pet industry’s needs are fully understood, protected, and prioritized in every major discussion and decision.”
In its new position, Pet Releaf will support compliance-driven industry standards, push for regulatory clarity regarding pet CBD products, and assist legislators in comprehending the particular requirements of veterinarians, pet parents, and animals that gain from hemp-based wellness solutions.
Pet Releaf has continuously promoted the responsible, transparent, and scientifically supported usage of hemp for pets. The business has actively participated in national regulatory discussions, state and federal advocacy campaigns, and research projects. This long-standing dedication is highlighted by its selection to the U.S. Hemp Roundtable Board, which further solidifies its leading position in influencing the direction of pet wellness in the hemp sector.
